{
    "id": 27414,
    "fullName": "ALK G1123S",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ALK G1123S lies within the protein kinase domain of the Alk protein (UniProt.org). G1123S has been demonstrated to confer drug resistance in culture (PMID: 26134233, PMID: 21948233), but has not been biochemically characterized and therefore, its effect on Alk protein function is unknown (PubMed, Sep 2019).",
            "references": [
                {
                    "id": 10632,
                    "pubMedId": 26134233,
                    "title": "Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26134233"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 5841,
                    "pubMedId": 21948233,
                    "title": "ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21948233"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 238,
        "geneSymbol": "ALK",
        "terms": [
            "ALK",
            "CD246",
            "NBLST3"
        ]
    },
    "variant": "G1123S",
    "createDate": "01/17/2018",
    "updateDate": "10/02/2019",
    "referenceTranscriptCoordinates": {
        "id": 102031,
        "transcript": "NM_004304",
        "gDna": "chr2:g.29222600C>T",
        "cDna": "c.3367G>A",
        "protein": "p.G1123S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12711,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, ALK G1123S was identified as an acquired mutation in a patient with ALK-rearranged lung adenocarcinoma whose disease relapsed 2 years after initial response to Zykadia (ceritinib) (PMID: 26134233).",
            "molecularProfile": {
                "id": 28864,
                "profileName": "ALK G1123S ALK rearrange"
            },
            "therapy": {
                "id": 789,
                "therapyName": "Ceritinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10632,
                    "pubMedId": 26134233,
                    "title": "Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26134233"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12712,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Alecensa (alectinib) treatment resulted in rapid response in a patient with ALK-rearranged lung adenocarcinoma with an acquired ALK G1123S mutation, whose disease had relapsed 2 years after initial response to Zykadia (ceritinib) (PMID: 26134233).",
            "molecularProfile": {
                "id": 28864,
                "profileName": "ALK G1123S ALK rearrange"
            },
            "therapy": {
                "id": 698,
                "therapyName": "Alectinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10632,
                    "pubMedId": 26134233,
                    "title": "Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26134233"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12757,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of ALK G1123S in neuroblastoma cells harboring an ALK F1174L mutation resulted in resistance to TAE684 in culture (PMID: 21948233).",
            "molecularProfile": {
                "id": 28914,
                "profileName": "ALK G1123S ALK F1174L"
            },
            "therapy": {
                "id": 2386,
                "therapyName": "TAE684",
                "synonyms": null
            },
            "indication": {
                "id": 769,
                "name": "neuroblastoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 5841,
                    "pubMedId": 21948233,
                    "title": "ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21948233"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28863,
            "profileName": "ALK G1123S",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28864,
            "profileName": "ALK G1123S ALK rearrange",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28914,
            "profileName": "ALK G1123S ALK F1174L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 102031,
            "transcript": "NM_004304",
            "gDna": "chr2:g.29222600C>T",
            "cDna": "c.3367G>A",
            "protein": "p.G1123S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}